In lung cancer and bladder cancer, METTL3 knockout can reduce the growth, survival and invasiveness of lung cancer cells, as well as the proliferation, invasion, in vitro survival and in vivo tumorigenicity of bladder cancer cells (Lin et al., 2016; Han et al., 2019). This evidence concerns the gene METTL3 and urinary bladder cancer.